GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza
Links shared publicly online about this topic.
- 569total visits
GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza
GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza
View full resource at us.gsk.com
Tags: Flu, Flu Medication, Relenza, GlaxoSmithKline
Most Recently Shared on January 19, 2011 at 2:42 pm By:
GSK commences Phase III study of intravenous zanamivir for hospitalized patients with influenza http://ow.ly/3Gsjp
Advertisement
